| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |